HomeZTS • NYSE
Zoetis Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 2.46B | 4.19% |
Operating expense | 822.00M | 4.45% |
Net income | 718.00M | 15.06% |
Net profit margin | 29.19 | 10.44% |
Earnings per share | 1.76 | 12.82% |
EBITDA | 1.11B | 7.65% |
Effective tax rate | 20.40% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.45B | -7.62% |
Total assets | 14.48B | 2.22% |
Total liabilities | 9.50B | 3.23% |
Total equity | 4.98B | — |
Shares outstanding | 443.18M | — |
Price to book | 13.65 | — |
Return on assets | 17.30% | — |
Return on capital | 21.29% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 718.00M | 15.06% |
Cash from operations | 486.00M | -3.19% |
Cash from investing | -247.00M | -87.12% |
Cash from financing | -564.00M | 26.08% |
Net change in cash | -286.00M | 28.68% |
Free cash flow | 198.00M | -6.33% |
Previous close
$153.06
Day range
$152.98 - $155.10
Year range
$139.70 - $200.33
Market cap
68.30B USD
Avg Volume
3.45M
P/E ratio
26.52
Dividend yield
1.30%
Primary exchange
NYSE
About
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Founded
1952
Headquarters
Website
Employees
13,800